Title
Category
Credits
Event date
Cost
  • 0.25 AMA PRA Category 1 Credit
$0.00
Bronchiolitis caused by respiratory syncytial virus (RSV) infection in infants is common and can lead to hospitalization if severe. There are now two ways to prevent this: immunizing the mother during pregnancy or giving monoclonal antibodies. Listen in as we discuss the recommendations for RSV prevention and how to best incorporate them into your practice.
  • Pharmacology
  • Sinusitis
  • 0.65 AANP Contact Hours
  • 0.65 AANP Pharmacology Contact Hours
  • 0.50 AMA PRA Category 1 Credit
$0.00
In this 30-minute podcast tailored for medical professionals, navigate the nuances of Acute Bacterial Rhinosinusitis (ABRS) as expert faculty discuss differentiating symptoms from acute rhinosinusitis. Gain practical insights on constructing effective treatment plans for ABRS in adults and acute bacterial sinusitis in pediatric populations, offering valuable guidance for appropriate antibiotic use in these scenarios. Stay informed and enhance your clinical decision-making skills in managing these common conditions.
  • Sinusitis
  • 0.25 AMA PRA Category 1 Credit
$0.00
There is an overlap of acute sinusitis symptoms and viral upper respiratory tract infection, such that many children are treated unnecessarily with antibiotics. In this episode, we review 2 recent studies that inform recommendations on whether or not to treat childhood sinusitis with amoxicillin/clavulanate. Gain practical strategies and the confidence to appropriately address sinusitis in the children you treat.
  • Anxiety
  • 0.25 AMA PRA Category 1 Credit
$0.00
New evidence points to the efficacy of a simple approach to managing and potentially curing generalized anxiety disorder. Join us to discuss this simple intervention and to review the diagnosis and treatment options for this prevalent disorder.
  • Hypertension
  • 0.25 AMA PRA Category 1 Credit
$0.00
There has been uncertainty as to the best time for patients to take blood pressure medications. Tune in as we review the Treatment in Morning versus Evening (TIME) study, which assessed whether morning or evening dosing improves cardiovascular outcomes.
  • Weight Management
  • 0.60 AANP Contact Hours
  • 0.50 AMA PRA Category 1 Credit
$0.00
In this podcast expert faculty will discuss the Obesity Medicine Association’s 4 pillars of clinical obesity treatment as a comprehensive, evidence-based approach to management, comprised of nutrition, physical activity, behavior, and medication. The discussion will encompass strategies and resources that PCPs can use to aid in implementing holistic care for people with obesity, including the roles and benefits of a multidisciplinary team and patient support networks in long-term planning for sustained weight management.
  • Anxiety
  • 0.25 AMA PRA Category 1 Credit
$0.00
This episode will explore a common syndrome that is often misdiagnosed and underdiagnosed. Listen in as we discuss the cardinal symptoms and diagnostic criteria for postural orthostatic tachycardia syndrome (POTS) and learn about different management options, including the benefits of salt. 
  • Weight Management
  • 0.48 AANP Contact Hours
  • 0.50 AMA PRA Category 1 Credit
$0.00
In this 30-minute podcast, expert faculty will discuss the concept of obesity as a chronic disease. They will consider the disease burden of obesity, including adiposity-related diseases and conditions, and will examine the evidence supporting the benefits of sustained weight loss, the pathophysiology of obesity and weight regain, and the shortcomings of lifestyle modifications alone in long-term weight management.
  • Alzheimer’s Disease
  • Cognitive Impairment
  • Pharmacology
  • 0.48 AANP Contact Hours
  • 0.48 AANP Pharmacology Contact Hours
  • 0.50 AMA PRA Category 1 Credit
$0.00
Embark on a captivating journey with our distinguished neurology faculty as they delve into the revolutionary world of FDA-approved monoclonal antibody therapies targeting β-amyloid in the treatment of Alzheimer disease (AD). Uncover clinical efficacy, safety nuances, and differences between these newer disease-modifying agents compared to older medications used for AD.
  • Alzheimer’s Disease
  • Cognitive Impairment
  • 0.48 AANP Contact Hours
  • 0.50 AMA PRA Category 1 Credit
$0.00
In this podcast, expert faculty bring you insights from the evolving area of Alzheimer disease diagnosis, including strategies for improving identification of cognitive decline and incorporating evidence-based tools in screening. Discover the impact of advanced neuroimaging and fluid markers, empowered by recent FDA approvals of anti-amyloid therapies. Come away with actionable knowledge to boost your role in cognitive health. 

Pages